AstraZeneca PLC - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AZN Nasdaq 2830 www.astrazeneca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca PLC

London's IPO Crisis Worsens--and AstraZeneca Could Join the Exodus - Jul 2nd, 2025 3:09 pm
Modella AI Announces Agreement to Accelerate AI-Driven Oncology Clinical Development - Jul 2nd, 2025 12:36 pm
What's Fueling Tempus AI's Explosive Sales Growth? - Jul 2nd, 2025 6:11 am
Trending tickers: AstraZeneca, Constellation Brands, Ford, Santander and Greggs - Jul 2nd, 2025 3:04 am
UK Stocks Trading Below Estimated Value In July 2025 - Jul 2nd, 2025 12:38 am
Astrazeneca (AZN) Advances While Market Declines: Some Information for Investors - Jul 1st, 2025 4:15 pm
Sector Update: Health Care Stocks Rise in Late Afternoon Trading - Jul 1st, 2025 1:56 pm
AstraZeneca Gains as U.S. Listing Move Considered - Jul 1st, 2025 1:24 pm
Sector Update: Health Care Stocks Advance Tuesday Afternoon - Jul 1st, 2025 11:55 am
AstraZeneca may quit London stock market - Jul 1st, 2025 10:13 am
Constellation Brands, AstraZeneca, casino stocks: Trending Tickers - Jul 1st, 2025 9:57 am
Top Midday Stories: Powell Blames Tariffs for Rate Pause; Tesla Shares Fall on Trump-Musk Feud - Jul 1st, 2025 9:43 am
AstraZeneca stock rises amid reports CEO favors US listing move - Jul 1st, 2025 9:12 am
AstraZeneca considers moving listing to US, the Times reports - Jul 1st, 2025 8:58 am
Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth - Jul 1st, 2025 7:35 am
CRO Activity and Intel Report, Q1 2025 Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung - Jul 1st, 2025 2:11 am
AstraZeneca (AZN) Announces Strategic Research Collaboration with CSPC Pharmaceuticals - Jun 30th, 2025 9:31 am
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025 - Jun 30th, 2025 1:00 am
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery - Jun 29th, 2025 1:03 am
AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer - Jun 28th, 2025 3:41 am